Pro MedicusASX:PME +1.88%98 Market Cap is A$19,732.3 Mil as of Jun. 27, 2026. GuruFocus rates ASX:PME with a GF Score™ of 98/100 and a GF Value™ of A$245.06 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 697 Healthcare Providers & Services companies, Pro Medicus ranks better than 98.57% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Pro Medicus's share price for the quarter that ended in Dec. 2025 was A$220.87. Pro Medicus's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 104.5 Mil. Therefore, Pro Medicus's market cap for the quarter that ended in Dec. 2025 was A$23,083.3 Mil.
Pro Medicus's quarterly market cap
increased
from Dec. 2024 (A$26,137.3 Mil) to Jun. 2025 (A$29,780.3 Mil) but then
declined
from Jun. 2025 (A$29,780.3 Mil) to Dec. 2025 (A$23,083.3 Mil).
Pro Medicus's annual market cap
increased
from Jun. 2023 (A$6,854.9 Mil) to Jun. 2024 (A$14,959.9 Mil) and
increased
from Jun. 2024 (A$14,959.9 Mil) to Jun. 2025 (A$29,780.3 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Pro Medicus's Enterprise Value for Today is A$19,511.2 Mil.
Pro Medicus (ASX:PME) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Pro Medicus Market Cap Related Terms
Pro Medicus Market Cap Historical Data
* Premium members only.
The historical data trend for Pro Medicus's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Pro Medicus's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pro Medicus Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's Market Cap distribution charts can be found below:
* The bar in red indicates where Pro Medicus's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Pro Medicus's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pro Medicus (ASX:PME) has a Market Cap of A$19,732.3 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Pro Medicus and its competitors. According to the industry distribution chart, Pro Medicus ranks #10 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 1.4%.
Is Pro Medicus' Market Cap too high?
Pro Medicus' current Market Cap is A$19,732.3 Mil. Based on the distribution chart, Pro Medicus ranks #10 out of 697 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Pro Medicus has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pro Medicus' Market Cap compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Pro Medicus ranks #10 out of 697 companies for Market Cap. This places Pro Medicus in the top 1% of its industry — outperforming the majority of peers. The industry median Market Cap is 93.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 93.63, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Pro Medicus and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 93.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pro Medicus's current Market Cap is A$19,732.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro Medicus stock overvalued right now?
Based on GuruFocus' analysis, Pro Medicus (ASX:PME) is currently considered Modestly Undervalued. The stock's GF Value™ is A$245.06, compared to a current price of A$188.88 — trading 22.9% below its estimated fair value. The current Market Cap is A$19,732.3 Mil. Pro Medicus' overall GF Score™ is 98/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Pro Medicus (ASX:PME), the current Market Cap is A$19,732.3 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pro Medicus (ASX:PME) Overvalued in 2026?
Based on GuruFocus' analysis, Pro Medicus stock appears to be undervalued.
The current stock price of A$188.88 is trading 22.9% below its estimated GF Value™ of A$245.06.
GuruFocus considers Pro Medicus to be Modestly Undervalued.
Key valuation signals for ASX:PME:
Market Cap: A$19,732.3 Mil
GF Value™: A$245.06 vs. price of A$188.88 (22.9% below fair value)
No single metric tells the full story. See the ASX:PME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2025, Pro Medicus earned 90% of revenue in North America, 8% from Australia, and the remaining 2% in Europe.
98GF Score
Get the complete analysis for ASX:PME
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:PME has been successfully added to your 
